Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer

Radiotherapy and Oncology

Volumn 109, Issue 1, 2013, Pages 13-20

  Guckenberger, Matthias ^a   Klement, Rainer Johannes ^a,b   Allgäuer, Michael ^c   Appold, Steffen ^d   Dieckmann, Karin ^e   Ernst, Iris ^f   Ganswindt, Ute ^g   Holy, Richard ^h   Nestle, Ursula ⁱ   Nevinny Stickel, Meinhard ^j   Semrau, Sabine ^k   Sterzing, Florian ^l   Wittig, Andrea ^m   Andratschke, Nicolaus ⁿ   Flentje, Michael ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b Leopoldina Hospital   (Germany)

^c Barmherzige Brüder Hospital   (Germany)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^g UNIVERSITY OF MUNICH   (Germany)

^h RWTH AACHEN UNIVERSITY   (Germany)

ⁱ UNIVERSITY OF FREIBURG   (Germany)

^j INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^k UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^l UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^m PHILIPPS UNIVERSITY MARBURG   (Germany)

ⁿ TECHNICAL UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

Biologically effective dose; Dose response modeling; Linear quadratic formalism; Non small cell lung cancer; Stereotactic body radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LINEAR QUADRATIC FORMALISM MODEL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROBABILITY; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; STATISTICAL MODEL; STEREOTACTIC BODY RADIATION THERAPY;

BIOLOGICALLY EFFECTIVE DOSE; DOSE-RESPONSE MODELING; LINEAR-QUADRATIC FORMALISM; NON-SMALL CELL LUNG CANCER; STEREOTACTIC BODY RADIOTHERAPY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; LINEAR MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROBABILITY; RADIOSURGERY;

EID: 84888046748     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.09.005     Document Type: Article

References (37)

1. J.F. Fowler The linear-quadratic formula and progress in fractionated radiotherapy Brit J Radiol 62 1989 679 694
2. H. Iwata, Y. Shibamoto, and R. Murata Estimation of errors associated with use of linear-quadratic formalism for evaluation of biologic equivalence between single and hypofractionated radiation doses: an in vitro study Int J Radiat Oncol Biol Phys 75 2009 482 488
3. Y. Shibamoto, S. Otsuka, and H. Iwata Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model J Radiat Res 53 2012 1 9
4. J.P. Grutters, A.G. Kessels, and M. Pijls-Johannesma Comparsion of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis Radiother Oncol 95 2010 32 40
5. A. Van Baardwijk, W.A. Tome, and W. Van Elmpt Is high-dose stereotactic body radiotherapy (SBRT) for stage I non-small cell lung cancer (NSCLC) overkill? A systematic review Radiother Oncol 105 2012 145 149
6. S. Senthi, C.J.A. Haasbeek, and B.J. Slotman Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review Radiother Oncol 106 2013 276 282
7. R.C. McGarry, L. Papiez, and M. Williams Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study Int J Radiat Oncol Biol Phys 63 2005 1010 1015
8. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
9. H. Hof, M. Muenter, and D. Oetzel Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC) Cancer 110 2007 148 155
10. P. Fritz, H.-J. Kraus, and T. Blaschke Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning Lung Cancer 60 2008 193 199
11. M. Guerrero, and X.A. Li Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy Phys Med Biol 49 2004 4825 4835
12. C. Park, L. Papiez, and Z. Chichuan Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy Int J Radiat Oncol Biol Phys 70 2008 847 852
13. M. Astrahan Some implications of linear-quadratic-linear radiation dose-response with regard to hypofractionation Med Phys 35 2008 4161 4172
14. J.Z. Wang, Z. Huang, and S.S. Lo A generalized linear-quadratic model for radiosurgery, stereotactic body radiation therapy, and high-dose rate brachytherapy Sci Transl Med 2 2010 39ra48
15. F.W. McKenna, and S. Ahmad Fitting techniques of cell survival curves in high-dose region for use in stereotactic body radiation therapy Phys Med Biol 54 2009 1593 1608
16. S. Otsuka, Y. Shibamoto, and H. Iwata Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor Int J Radiat Oncol Biol Phys 81 2011 1538 1543
17. G.R. Borst, M. Ishikawa, and J. Nijkamp Radiation pneumonitis after hypofractionated radiotherapy: evaluation of the LQ(L) model and different dose parameters Int J Radiat Oncol Biol Phys 77 2010 1596 1603
18. B.M. Wennberg, P. Baumann, and G. Gagliardi NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction Acta Oncol 50 2011 518 527
19. P. Okunieff, D. Morgan, and A. Niemierko Radiation dose-response of human tumors Int J Radiat Oncol Biol Phys 32 1995 1227 1237
20. J. Kruschke Doing Bayesian data analysis: a tutorial introduction with R 2010 Academic Press p. 672
21. R.E. Kass, and A.E. Raftery Bayes factors J Am Statist Assoc 90 1995 773 795
22. R.E. Kass Bayes factors in practice The Statistician 42 1993 551 560
23. D.J.C. MacKay Information theory, inference and learning algorithms 2003 Cambridge University Press p. 640
24. M. Guckenberger, M. Allgäuer, and S. Appold Safety and Efficacy of Stereotactic Body Radiotherapy for Stage I Non-Small-Cell Lung Cancer in Routine Clinical Practice: A Patterns-of-Care and Outcome Analysis J Thorac Oncol 2013
25. C. Hurkmans, J. Cuijpers, and F. Lagerwaard Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study Radiat Oncol 4 2009 1
26. U. Haedinger, T. Krieger, and M. Flentje Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets Int J Radiat Oncol Biol Phys 61 2005 239 249
27. M. Guckenberger, J. Wulf, and G. Mueller Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation Int J Radiat Oncol Biol Phys 74 2009 47 54
28. J. Wulf, K. Baier, and G. Mueller Dose-response in stereotactic irradiation of lung tumors Radiother Oncol 77 2005 83 87
29. R. Onimaru, M. Fujino, and K. Yamazaki Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy Int J Radiat Oncol Biol Phys 70 2008 374 381
30. J.R. Olsen, C.G. Robinson, and I. El Naqa Dose-response for stereotactic body radiotherapy in early-stage non-small-cell lung cancer Int J Radiat Oncol Biol Phys 81 2011 e299 e303
31. N. Ohri, M. Werner-Wasik, and I.S. Grills Modeling local control after hypofractionated stereotactic body radiation therapy for stage I non-small cell lung cancer: a report from the elekta collaborative lung research group Int J Radiat Oncol Biol Phys 84 2012 e379 e384
32. H. Onishi, T. Araki, and H. Shirato Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study Cancer 101 2004 1623 1631
33. J. Zhang, F. Yang, and B. Li Which is the optimal biologically effective dose of stereotactic body radiotherapy for Stage I non-small-cell lung cancer? A meta-analysis Int J Radiat Oncol Biol Phys 81 2011 e305 e316
34. Q.-T. Le, B.W. Loo, and A. Ho Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors J Thorac Oncol 1 2006 802 809
35. M. Guckenberger, J. Wilbert, and T. Krieger Four-dimensional treatment planning for stereotactic body radiotherapy Int J Radiat Oncol Biol Phys 69 2007 276 285
36. D.J. Brenner The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction Semin Radiat Oncol 18 2008 234 239
37. K. Huang, M. Dahele, and S. Senau Radiographic changes after lung stereotactic ablative radiotherapy (SABR) - can we distinguish recurrence from fibrosis? A systematic review of the literature Radiother Oncol 102 2012 335 342